This study, with Fred Locke as corresponding author, shows that allogeneic CAR T cells can elicit durable complete responses against lymphoma.
CART persistence>4 months. No severe CRS and no GVHD, paving the way for a new geenration of "off-the-shelf" CART

https://ascopubs.org/doi/10.1200/JCO-24-01933